Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Novartis Pharmaceuticals
Novartis Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Novartis Investigative Site
CABA, Buenos Aires, Argentina
Recruiting - Novartis Investigative Site
CABA, Buenos Aires, Argentina
Recruiting - Novartis Investigative Site
Córdoba, Córdoba Province, Argentina
Recruiting
- Novartis Investigative Site
Ashdod, Israel
Recruiting - Novartis Investigative Site
Hadera, Israel
Recruiting - Novartis Investigative Site
Haifa, Israel
Recruiting - Novartis Investigative Site
Nahariya, Israel
Recruiting
- Novartis Investigative Site
Kuala Lumpur, Selangor, Malaysia
Recruiting
- Novartis Investigative Site
Riyadh, Saudi Arabia
Recruiting
- University of Alabama at Birmingham
Birmingham, Alabama, United States
Dana RizkRecruiting - Ucla Medical Center
Los Angeles, California, United States
Mrinalini SarkarRecruiting - Central Florida Kidney Specialists
Orlando, Florida, United States
Arvind MadanRecruiting - Georgia Nephrology Research Inst
Lawrenceville, Georgia, United States
James A TumlinRecruiting - Care Research
Chubbuck, Idaho, United States
Hira SiktelRecruiting - Davita Clinical Research
Las Vegas, Nevada, United States
Mark VishnepolskyRecruiting - University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Andrew LazarRecruiting - Osu Wexner Medical Center
Columbus, Ohio, United States
Isabelle AyoubRecruiting - Prolato Clinical Research Center
Houston, Texas, United States
Sreedhar MandayamRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Feb 2025
- Primary completion
- 27 Nov 2027
- Completion
- 27 Nov 2027
- Last update posted
- 27 Apr 2026
- Registered enrollment
- 20
- Registry id
- NCT06797518
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.